Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 1

Status

Recruiting 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Advanced Solid Tumors 27Advanced Solid Tumor 26Solid Tumor 13Solid Tumors 6Advanced Solid Tumour 5Advanced Malignant Solid Tumor 4Metastatic Solid Tumors 2Mesothelioma 2Advanced or Metastatic Solid Tumors 2mCRPC (Metastatic Castration-resistant Prostate Cancer) 1Uveal Melanoma 1Solid Tumor, Adult 1Pediatric Solid Tumor, Unspecified, Protocol Specific 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Malignant Solid Tumors 1Malignant Solid Tumor 1Locally Advanced/Metastatic Solid Tumours 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Solid Tumor 1HER2-Positive Solid Tumors 1Docetaxel 1Colorectal Neoplasms 1Advanced/Metastatic Solid Tumors 1Advanced Solid Tumours 1Advanced Solid Tumors Cancer 1Advanced Solid Tumors - Phase 1 Population 1Advanced Solid Tumor (Phase 1) 1Advanced Malignant Solid Tumours 1

Interventions

Injections 4Granulocyte-Macrophage Colony-Stimulating Factor 2Colony-Stimulating Factors 2nabiximols 1fludarabine 1camrelizumab 1Radiofrequency Ablation 1Interleukin-2 1Immune Checkpoint Inhibitors 1Cyclophosphamide 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumor × Injections × Other solid neoplasm × Clear all
NCT07326488 2026-04-13

A Study of MHB009C in Patients With Advanced Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
200 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07192107 2026-04-09

A Study of MHB042C in Patients With Advanced Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
200 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07126665 2025-11-18

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
116 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07045454 2025-07-01

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1 Recruiting
200 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡